Cargando…
CARD10 cleavage by MALT1 restricts lung carcinoma growth in vivo
CARD-CC complexes involving BCL10 and MALT1 are major cellular signaling hubs. They govern NF-κB activation through their scaffolding properties as well as MALT1 paracaspase function, which cleaves substrates involved in NF-κB regulation. In human lymphocytes, gain-of-function defects in this pathwa...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024357/ https://www.ncbi.nlm.nih.gov/pubmed/33824280 http://dx.doi.org/10.1038/s41389-021-00321-2 |
_version_ | 1783675297476902912 |
---|---|
author | Israël, Laura Glück, Anton Berger, Marjorie Coral, Marine Ceci, Melanie Unterreiner, Adeline Rubert, Joëlle Bardet, Maureen Ginster, Stefanie Golding-Ochsenbein, Alexandra M. Martin, Kea Hoyler, Thomas Calzascia, Thomas Wieczorek, Grazyna Hillenbrand, Rainer Ferretti, Stéphane Ferrero, Enrico Bornancin, Frédéric |
author_facet | Israël, Laura Glück, Anton Berger, Marjorie Coral, Marine Ceci, Melanie Unterreiner, Adeline Rubert, Joëlle Bardet, Maureen Ginster, Stefanie Golding-Ochsenbein, Alexandra M. Martin, Kea Hoyler, Thomas Calzascia, Thomas Wieczorek, Grazyna Hillenbrand, Rainer Ferretti, Stéphane Ferrero, Enrico Bornancin, Frédéric |
author_sort | Israël, Laura |
collection | PubMed |
description | CARD-CC complexes involving BCL10 and MALT1 are major cellular signaling hubs. They govern NF-κB activation through their scaffolding properties as well as MALT1 paracaspase function, which cleaves substrates involved in NF-κB regulation. In human lymphocytes, gain-of-function defects in this pathway lead to lymphoproliferative disorders. CARD10, the prototypical CARD-CC protein in non-hematopoietic cells, is overexpressed in several cancers and has been associated with poor prognosis. However, regulation of CARD10 remains poorly understood. Here, we identified CARD10 as the first MALT1 substrate in non-hematopoietic cells and showed that CARD10 cleavage by MALT1 at R587 dampens its capacity to activate NF-κB. Preventing CARD10 cleavage in the lung tumor A549 cell line increased basal levels of IL-6 and extracellular matrix components in vitro, and led to increased tumor growth in a mouse xenograft model, suggesting that CARD10 cleavage by MALT1 might be a built-in mechanism controlling tumorigenicity. |
format | Online Article Text |
id | pubmed-8024357 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-80243572021-04-21 CARD10 cleavage by MALT1 restricts lung carcinoma growth in vivo Israël, Laura Glück, Anton Berger, Marjorie Coral, Marine Ceci, Melanie Unterreiner, Adeline Rubert, Joëlle Bardet, Maureen Ginster, Stefanie Golding-Ochsenbein, Alexandra M. Martin, Kea Hoyler, Thomas Calzascia, Thomas Wieczorek, Grazyna Hillenbrand, Rainer Ferretti, Stéphane Ferrero, Enrico Bornancin, Frédéric Oncogenesis Article CARD-CC complexes involving BCL10 and MALT1 are major cellular signaling hubs. They govern NF-κB activation through their scaffolding properties as well as MALT1 paracaspase function, which cleaves substrates involved in NF-κB regulation. In human lymphocytes, gain-of-function defects in this pathway lead to lymphoproliferative disorders. CARD10, the prototypical CARD-CC protein in non-hematopoietic cells, is overexpressed in several cancers and has been associated with poor prognosis. However, regulation of CARD10 remains poorly understood. Here, we identified CARD10 as the first MALT1 substrate in non-hematopoietic cells and showed that CARD10 cleavage by MALT1 at R587 dampens its capacity to activate NF-κB. Preventing CARD10 cleavage in the lung tumor A549 cell line increased basal levels of IL-6 and extracellular matrix components in vitro, and led to increased tumor growth in a mouse xenograft model, suggesting that CARD10 cleavage by MALT1 might be a built-in mechanism controlling tumorigenicity. Nature Publishing Group UK 2021-04-06 /pmc/articles/PMC8024357/ /pubmed/33824280 http://dx.doi.org/10.1038/s41389-021-00321-2 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Israël, Laura Glück, Anton Berger, Marjorie Coral, Marine Ceci, Melanie Unterreiner, Adeline Rubert, Joëlle Bardet, Maureen Ginster, Stefanie Golding-Ochsenbein, Alexandra M. Martin, Kea Hoyler, Thomas Calzascia, Thomas Wieczorek, Grazyna Hillenbrand, Rainer Ferretti, Stéphane Ferrero, Enrico Bornancin, Frédéric CARD10 cleavage by MALT1 restricts lung carcinoma growth in vivo |
title | CARD10 cleavage by MALT1 restricts lung carcinoma growth in vivo |
title_full | CARD10 cleavage by MALT1 restricts lung carcinoma growth in vivo |
title_fullStr | CARD10 cleavage by MALT1 restricts lung carcinoma growth in vivo |
title_full_unstemmed | CARD10 cleavage by MALT1 restricts lung carcinoma growth in vivo |
title_short | CARD10 cleavage by MALT1 restricts lung carcinoma growth in vivo |
title_sort | card10 cleavage by malt1 restricts lung carcinoma growth in vivo |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024357/ https://www.ncbi.nlm.nih.gov/pubmed/33824280 http://dx.doi.org/10.1038/s41389-021-00321-2 |
work_keys_str_mv | AT israellaura card10cleavagebymalt1restrictslungcarcinomagrowthinvivo AT gluckanton card10cleavagebymalt1restrictslungcarcinomagrowthinvivo AT bergermarjorie card10cleavagebymalt1restrictslungcarcinomagrowthinvivo AT coralmarine card10cleavagebymalt1restrictslungcarcinomagrowthinvivo AT cecimelanie card10cleavagebymalt1restrictslungcarcinomagrowthinvivo AT unterreineradeline card10cleavagebymalt1restrictslungcarcinomagrowthinvivo AT rubertjoelle card10cleavagebymalt1restrictslungcarcinomagrowthinvivo AT bardetmaureen card10cleavagebymalt1restrictslungcarcinomagrowthinvivo AT ginsterstefanie card10cleavagebymalt1restrictslungcarcinomagrowthinvivo AT goldingochsenbeinalexandram card10cleavagebymalt1restrictslungcarcinomagrowthinvivo AT martinkea card10cleavagebymalt1restrictslungcarcinomagrowthinvivo AT hoylerthomas card10cleavagebymalt1restrictslungcarcinomagrowthinvivo AT calzasciathomas card10cleavagebymalt1restrictslungcarcinomagrowthinvivo AT wieczorekgrazyna card10cleavagebymalt1restrictslungcarcinomagrowthinvivo AT hillenbrandrainer card10cleavagebymalt1restrictslungcarcinomagrowthinvivo AT ferrettistephane card10cleavagebymalt1restrictslungcarcinomagrowthinvivo AT ferreroenrico card10cleavagebymalt1restrictslungcarcinomagrowthinvivo AT bornancinfrederic card10cleavagebymalt1restrictslungcarcinomagrowthinvivo |